Cargando…
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy
Cancer immunotherapy that deploys the host’s immune system to recognize and attack tumors, is a promising strategy for cancer treatment. However, its efficacy is greatly restricted by the immunosuppressive (i.e., immunologically cold) tumor microenvironment (TME). Here, we report an in-situ cryo-imm...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873931/ https://www.ncbi.nlm.nih.gov/pubmed/36693842 http://dx.doi.org/10.1038/s41467-023-36045-7 |
_version_ | 1784877690364362752 |
---|---|
author | Ou, Wenquan Stewart, Samantha White, Alisa Kwizera, Elyahb A. Xu, Jiangsheng Fang, Yuanzhang Shamul, James G. Xie, Changqing Nurudeen, Suliat Tirada, Nikki P. Lu, Xiongbin Tkaczuk, Katherine H. R. He, Xiaoming |
author_facet | Ou, Wenquan Stewart, Samantha White, Alisa Kwizera, Elyahb A. Xu, Jiangsheng Fang, Yuanzhang Shamul, James G. Xie, Changqing Nurudeen, Suliat Tirada, Nikki P. Lu, Xiongbin Tkaczuk, Katherine H. R. He, Xiaoming |
author_sort | Ou, Wenquan |
collection | PubMed |
description | Cancer immunotherapy that deploys the host’s immune system to recognize and attack tumors, is a promising strategy for cancer treatment. However, its efficacy is greatly restricted by the immunosuppressive (i.e., immunologically cold) tumor microenvironment (TME). Here, we report an in-situ cryo-immune engineering (ICIE) strategy for turning the TME from immunologically “cold” into “hot”. In particular, after the ICIE treatment, the ratio of the CD8(+) cytotoxic T cells to the immunosuppressive regulatory T cells is increased by more than 100 times in not only the primary tumors with cryosurgery but also distant tumors without freezing. This is achieved by combining cryosurgery that causes “frostbite” of tumor with cold-responsive nanoparticles that not only target tumor but also rapidly release both anticancer drug and PD-L1 silencing siRNA specifically into the cytosol upon cryosurgery. This ICIE treatment leads to potent immunogenic cell death, which promotes maturation of dendritic cells and activation of CD8(+) cytotoxic T cells as well as memory T cells to kill not only primary but also distant/metastatic breast tumors in female mice (i.e., the abscopal effect). Collectively, ICIE may enable an efficient and durable way to leverage the immune system for combating cancer and its metastasis. |
format | Online Article Text |
id | pubmed-9873931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-98739312023-01-26 In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy Ou, Wenquan Stewart, Samantha White, Alisa Kwizera, Elyahb A. Xu, Jiangsheng Fang, Yuanzhang Shamul, James G. Xie, Changqing Nurudeen, Suliat Tirada, Nikki P. Lu, Xiongbin Tkaczuk, Katherine H. R. He, Xiaoming Nat Commun Article Cancer immunotherapy that deploys the host’s immune system to recognize and attack tumors, is a promising strategy for cancer treatment. However, its efficacy is greatly restricted by the immunosuppressive (i.e., immunologically cold) tumor microenvironment (TME). Here, we report an in-situ cryo-immune engineering (ICIE) strategy for turning the TME from immunologically “cold” into “hot”. In particular, after the ICIE treatment, the ratio of the CD8(+) cytotoxic T cells to the immunosuppressive regulatory T cells is increased by more than 100 times in not only the primary tumors with cryosurgery but also distant tumors without freezing. This is achieved by combining cryosurgery that causes “frostbite” of tumor with cold-responsive nanoparticles that not only target tumor but also rapidly release both anticancer drug and PD-L1 silencing siRNA specifically into the cytosol upon cryosurgery. This ICIE treatment leads to potent immunogenic cell death, which promotes maturation of dendritic cells and activation of CD8(+) cytotoxic T cells as well as memory T cells to kill not only primary but also distant/metastatic breast tumors in female mice (i.e., the abscopal effect). Collectively, ICIE may enable an efficient and durable way to leverage the immune system for combating cancer and its metastasis. Nature Publishing Group UK 2023-01-24 /pmc/articles/PMC9873931/ /pubmed/36693842 http://dx.doi.org/10.1038/s41467-023-36045-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ou, Wenquan Stewart, Samantha White, Alisa Kwizera, Elyahb A. Xu, Jiangsheng Fang, Yuanzhang Shamul, James G. Xie, Changqing Nurudeen, Suliat Tirada, Nikki P. Lu, Xiongbin Tkaczuk, Katherine H. R. He, Xiaoming In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
title | In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
title_full | In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
title_fullStr | In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
title_full_unstemmed | In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
title_short | In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
title_sort | in-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873931/ https://www.ncbi.nlm.nih.gov/pubmed/36693842 http://dx.doi.org/10.1038/s41467-023-36045-7 |
work_keys_str_mv | AT ouwenquan insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT stewartsamantha insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT whitealisa insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT kwizeraelyahba insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT xujiangsheng insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT fangyuanzhang insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT shamuljamesg insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT xiechangqing insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT nurudeensuliat insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT tiradanikkip insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT luxiongbin insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT tkaczukkatherinehr insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy AT hexiaoming insitucryoimmuneengineeringoftumormicroenvironmentwithcoldresponsivenanotechnologyforcancerimmunotherapy |